The largest database of trusted experimental protocols

Pipeline pilot platform

Manufactured by Dassault Systèmes

Pipeline Pilot is a platform for creating and running automated scientific workflows. It allows users to integrate various data sources, applications, and algorithms into a unified environment for data processing, analysis, and visualization.

Automatically generated - may contain errors

5 protocols using pipeline pilot platform

1

Ependymoma Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suspensions of the indicated single cells were seeded in 30 µl of Neurobasal medium in each well of 384-well plates (Corning) using an automated plate filler (Wellmate, Matrix). The RTBDN-driven model of ependymoma was used for these studies since this tumor mode most closely recapitulated the morphology of ependymoma in the cerebrum (Fig. 4b). After 24 hours, 60 nL of solution containing appropriate compounds were pin transferred into the 384-well plates to provide the desired and indicated final drug concentration. Each plate also included DMSO only negative controls and cycloheximide single point (0.5µM) and dose-response (0.5 µM-0.01 nM) positive controls. Cell number was determined in each well using the Cell Titer Glo reagent (Promega) and read in an automated Envision plate reader (Perkin-Elmer) after 72 hours incubation. Luminescence data were normalized by log10 transformation and the percentage inhibition = 100 × (sample result – negative control mean)/(positive control mean – negative control mean) calculated. All studies were repeated in triplicate. All data processing and visualization was performed using custom programs written in the Pipeline Pilot platform (Accelrys, v.7.0.1) and the R program.
+ Open protocol
+ Expand
2

Ependymoma Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suspensions of the indicated single cells were seeded in 30 µl of Neurobasal medium in each well of 384-well plates (Corning) using an automated plate filler (Wellmate, Matrix). The RTBDN-driven model of ependymoma was used for these studies since this tumor mode most closely recapitulated the morphology of ependymoma in the cerebrum (Fig. 4b). After 24 hours, 60 nL of solution containing appropriate compounds were pin transferred into the 384-well plates to provide the desired and indicated final drug concentration. Each plate also included DMSO only negative controls and cycloheximide single point (0.5µM) and dose-response (0.5 µM-0.01 nM) positive controls. Cell number was determined in each well using the Cell Titer Glo reagent (Promega) and read in an automated Envision plate reader (Perkin-Elmer) after 72 hours incubation. Luminescence data were normalized by log10 transformation and the percentage inhibition = 100 × (sample result – negative control mean)/(positive control mean – negative control mean) calculated. All studies were repeated in triplicate. All data processing and visualization was performed using custom programs written in the Pipeline Pilot platform (Accelrys, v.7.0.1) and the R program.
+ Open protocol
+ Expand
3

High-Throughput Cell Viability Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
A high-throughput screening approach has been previously reported.17 (link) Briefly, cells were seeded in 30 μL of neurobasal medium in each well of 384-well plates (Corning) using an automated plate filler (Wellmate, Matrix). After 24 h, 25 nL of solution containing appropriate compounds were pin transferred into the 384-well plates resulting in approximately 8.3 mM final drug concentration. Each plate included DMSO and cycloheximide as controls. The cell number was determined in each well using the Cell Titer Glo reagent (Promega) and read in an automated Envision plate reader (Perkin-Elmer) after 96 h incubation. Luminescence data were normalized by log10 transformation and the percentage inhibition was calculated. Secondary screens were conducted in a similar manner although compounds were applied in a dilution series (8.3 mM to 0.5 nM final concentration) and repeated in triplicate. All data processing and visualization was performed using custom programs written in the Pipeline Pilot platform (Accelrys, v.7.0.1) and the R program.
+ Open protocol
+ Expand
4

Cell Proliferation Monitoring Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To monitor proliferation of reporter cell lines in the presence of library compounds, 15 μL of DME-L medium [20 (link)] containing 5 mM glucose and 10% heat inactivated fetal bovine serum was dispensed into each well of 384-well microplates (black polystyrene, clear bottom, tissue culture treated, Corning) with a Matrix Wellmate liquid dispenser (Thermo Scientific). Stock compounds dissolved in dimethyl sulfoxide (DMSO) were pin-transferred (V&P Scientific) into the microplate to the desired final concentration using an automated robot arm. 15 μL of the reporter cell line, e.g., Δlmxgt1-3[pPfHT], at 2 x 106/mL was added per well with the Wellmate dispenser. Microplates were incubated (Liconic) at 28°C and 5% CO2 for 72 h. After incubation, 10 μL of the reading solution (5X SYBR Green prepared from a commercial 100X stock, SIGMA, 5% Triton-X in PBS) was added per well. Each plate was shaken at 1000 rpm for one min, incubated further at room temperature for 20 min, and then fluorescence was read (excitation 485 nm, emission 535 nm) with the Envision plate reader (PerkinElmer). All data processing and visualization, as well as chemical similarity and substructure analysis, was performed using custom programs written in the Pipeline Pilot platform (Accelrys, v.7.0.1) and the R program [21 ].
+ Open protocol
+ Expand
5

High-Throughput Glucose Uptake Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure uptake of glucose in a medium throughput format, 100 μL/well of PBS was added to 96-well filter plates (Millipore) with the Wellmate dispenser. Control wells included either 0 mM (positive control) or 20 mM (negative control) of the competitive inhibitor fructose in PBS. Compounds were added with the Biomek FX automated system. 90 μl of a cell suspension (1.1 x 108 cells/mL) was added to each well with the Wellmate dispenser and left at room temperature for 5 minutes before adding 10 μL of the substrate (4 mM [3H] D-glucose at 50 μCi/mL) to provide a final glucose concentration of 200 μM. After a 5 min incubation, the uptake reaction was stopped by adding 50 μL/well of 4% formaldehyde, followed by incubation for ~5 min. Cells were filtered and washed with a vacuum manifold (Millipore). Plates were dried overnight, 100 μL of scintillation fluid were added, and plates were then sealed and read on a TopCount NXT HTS from PerkinElmer. Data quality and analysis was performed using the GUItars program [22 (link)] and sigmoidal curve fitting with Pipeline Pilot platform (Accelrys, v. 7.0.1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!